Press release

Registration

Powered by ChronoForms - ChronoEngine.com

Flex Databases team - Olga Loginovskaya, MD Chief Quality and Corporate Officer and Natalia Blagodarova, QA Department Director, took part in Quality Assurance Forum in Moscow, Skolkovo Innovation Forum on December 14th.

This forum is gathering QA experts from the pharmaceutical industry (preclinical and clinical research, drug development and pharmacovigilance) to discuss quality management issues and exchange experience with each other.

Natalia Blagodarova covered the topic: Risk-Based Approach to GCP e-systems validation.

If you want to learn more about the topic or anything else related to clinical trials e-systems, contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. 

You may also be interested in
Categories
Flex Databases is always ready to support you in any challenging situation. And today, when GDPR came into effect, we are here to demonstrate that with us you are fully prepared to it in terms of our...
Clinical Trials are notoriously expensive to operate, with the majority of trial sites working with no more than a 3-month operating budget. That means that maintaining up-to-date financial records, a...
The past few years have created something of a boom in the development of Blockchain technology and its emerging applications within various industries and spheres of life. Following our strategic pol...
Last week Timur Galimov, our Chief Technology Officer, and Olga Sokolova, System Analysis Director, conducted a 2-day training for our client Novo Nordisk, a global healthcare company with more than 9...
Filters

Tags

DIABIOIPhEBCTMSEDCLMSe-CRFFDACRO

Powered by ChronoForms - ChronoEngine.com

Request Demo

Get in touch for a demo of our system. Fill in the form and we’ll contact you to demonstrate the system in action.

Powered by ChronoForms - ChronoEngine.com

Ваша заявка отправлена

Спасибо за Ваш интерес! Вы подписаны на нашу новостную рассылку.

Your request send

Thank you for your interest! You are subscribed to our newsletter